Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mi OL-B6
- Development stage
- Unknown
- Lead developer
- Astra IDL
- Administration
- Oral
01
Overview
**Mi OL-B6** is a fixed-dose nutritional supplement developed by Astra IDL containing mecobalamin, folic acid, and pyridoxine. It provides vitamins B12, B9, and B6 to correct or prevent deficiency states and to support vitamin-dependent processes including red-blood-cell formation, one-carbon metabolism, amino-acid metabolism, and normal neurologic function.
- Brand names
- Mi OL-B6
- Other names
- folic acid + mecobalamin + pyridoxineMecobalamin + Folic Acid + Pyridoxinemethylcobalamin + folic acid + pyridoxine
02
Targets
MTR (Methionine synthase)PDXK (Pyridoxal kinase)DHFR (Dihydrofolate reductase)
Beyond the preview
Go deeper on Mi OL-B6.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mi OL-B6.